by Sasha Nimmo in ME Australia.
Queensland’s Griffith University is home to the National Centre for Neuroimmunology and Emerging Diseases (NCNED), one of the leading centres for research in ME and chronic fatigue syndrome. They’ve been in the news lately for their patented biomarker discovery on calcium channel ion defects in patients.
The words ‘breakthrough’ and ‘finally’ have been bandied about for decades. For example, here’s a 1990 article from the New York Times ‘Chronic Fatigue Syndrome Finally Gets Some Respect‘. What does this latest research news mean for Australians and globally?
Griffith researchers identified a dysfunctional cell receptor in the immune system.
The class of receptors TRPM3 belongs to are known as ‘threat receptors’, because they’re upregulated when the body is under any kind of threat, such as infection, trauma or even childbirth.
To read the rest of this story, click on the link below: